Protection from obesity in mice lacking the VLDL receptor

被引:106
作者
Goudriaan, JR
Tacken, PJ
Dahlmans, VEH
Gijbels, MJJ
van Dijk, KW
Havekes, LM
Jong, MC
机构
[1] TNO, Gaubius Lab, NL-2301 CE Leiden, Netherlands
[2] Leiden Univ, Med Ctr, MGC Dept Human Genet, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands
关键词
VLDL receptor; obesity; fatty acid transport; triglyceride metabolism; transgenic mice;
D O I
10.1161/hq0901.095147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has previously been reported that mice lacking the VLDL receptor (VLDLR-/-) exhibit normal plasma lipid levels and a modest decrease in adipose tissue mass. In the present study, the effect of VLDLR deficiency on profound weight gain was studied in mice. Obesity was induced either by feeding of a high-fat, high-calorie (HFC) diet or by crossbreeding mice onto the genetically obese ob/ob background. After 17 weeks of HFC feeding, VLDLR-/- mice remained lean, whereas their wild-type littermates (VLDLR+/+) became obese. Similarly, the weight gain of ob/ob mice was less profound in the absence of the VLDLR. Moreover, VLDLR deficiency led to increased plasma triglycerides after HFC feeding. The protection from obesity in VLDLR-/- mice involved decreased peripheral uptake of fatty acids, because VLDLR-/- mice exhibited a significant reduction in whole-body free fatty acid uptake, with no clear differences in food intake and fat absorption. These observations were supported by a strong decrease in average adipocyte size in VLDLR-/- mice of both obesity models, implying reduced adipocyte triglyceride storage in the absence of the VLDLR. These results suggest that the VLDLR plays a role in the delivery of VLDL-derived fatty acids into adipose tissue.
引用
收藏
页码:1488 / 1493
页数:6
相关论文
共 30 条
  • [1] MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES
    AALTOSETALA, K
    FISHER, EA
    CHEN, XL
    CHAJEKSHAUL, T
    HAYEK, T
    ZECHNER, R
    WALSH, A
    RAMAKRISHNAN, R
    GINSBERG, HN
    BRESLOW, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1889 - 1900
  • [2] THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR MEDIATES THE CELLULAR CATABOLISM OF LIPOPROTEIN-LIPASE AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I COMPLEXES
    ARGRAVES, KM
    BATTEY, FD
    MACCALMAN, CD
    MCCRAE, KR
    GAFVELS, M
    KOZARSKY, KF
    CHAPPELL, DA
    STRAUSS, JF
    STRICKLAND, DK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) : 26550 - 26557
  • [3] BATTEY FD, 1994, J BIOL CHEM, V269, P23268
  • [4] Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors
    Beisiegel, U
    Heeren, J
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1997, 56 (02) : 731 - 737
  • [5] DOSE-DEPENDENT EFFECT OF INSULIN ON PLASMA-FREE FATTY-ACID TURNOVER AND OXIDATION IN HUMANS
    BONADONNA, RC
    GROOP, LC
    ZYCH, K
    SHANK, M
    DEFRONZO, RA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (05): : E736 - E750
  • [6] NORMAL PLASMA-LIPOPROTEINS AND FERTILITY IN GENE-TARGETED MICE HOMOZYGOUS FOR A DISRUPTION IN THE GENE ENCODING VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR
    FRYKMAN, PK
    BROWN, MS
    YAMAMOTO, T
    GOLDSTEIN, JL
    HERZ, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8453 - 8457
  • [7] In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
    Jong, MC
    Dahlmans, VEH
    vanGorp, PJJ
    vanDijk, KW
    Breuer, ML
    Hofker, MH
    Havekes, LM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) : 2259 - 2267
  • [8] Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor
    Jong, MC
    Van Dijk, KW
    Dahlmans, VEH
    Van der Boom, H
    Kobayashi, K
    Oka, K
    Siest, G
    Chan, L
    Hofker, MH
    Havekes, LM
    [J]. BIOCHEMICAL JOURNAL, 1999, 338 : 281 - 287
  • [9] Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1
    Jong, MC
    Gijbels, MJJ
    Dahlmans, VEH
    van Gorp, PJJ
    Koopman, SJ
    Ponec, M
    Hofker, MH
    Havekes, LM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) : 145 - 152
  • [10] Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor
    Kobayashi, K
    Oka, K
    Forte, T
    Ishida, B
    Teng, BB
    IshimuraOka, K
    Nakamuta, M
    Chan, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) : 6852 - 6860